Testing Testosterone Levels in Patients
Testosterone testing is recommended for all men diagnosed with organic erectile dysfunction, especially in those for whom PDE5 inhibitor therapy has failed. 1
Indications for Testosterone Testing
Primary indications:
Specific patient populations who should be tested:
Testing Procedure and Methodology
Collection Timing
- Morning collection is essential (8-11 AM) due to circadian variation 3
- Blood drawn between 8-11 AM shows significantly higher levels (411.7 ng/dL) compared to afternoon/evening draws (368.3 ng/dL) 3
- If needed, the collection window may be extended to include 11 AM-2 PM, as values don't differ significantly from the 8-11 AM window 3
Recommended Testing Protocol
- Obtain fasting morning samples on two or more occasions 4
- Measure total testosterone using reliable assay methods 5
- Consider free testosterone measurement when:
Preferred Laboratory Methods
- Gold standard: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) 4
- Use laboratories certified by accuracy-based programs (e.g., CDC's Hormone Standardization Program) 4
- For free testosterone, equilibrium dialysis is the preferred method 4
- Avoid immunoassays for women or men with borderline low levels due to accuracy issues 6
Additional Testing Considerations
When Evaluating Erectile Dysfunction
- Include testosterone testing as part of a comprehensive cardiovascular risk assessment 1
- Consider additional tests:
- Resting electrocardiogram
- Blood pressure measurement
- Waist circumference and BMI 1
For Diabetic Patients
- Morning total testosterone measurement is recommended for men with diabetes showing symptoms of hypogonadism 1
- Consider free testosterone calculations using total testosterone, sex hormone binding globulin, and albumin concentrations for borderline cases 1
Interpretation and Follow-up
Target Ranges
- Normal total testosterone range: 300-1000 ng/dL 7
- Target range for replacement therapy: 450-600 ng/dL 2
Monitoring Parameters
If low testosterone is identified and treatment initiated:
- Monitor testosterone levels, hematocrit, and PSA every 3-6 months during first year of treatment 2
- Watch for hematocrit exceeding 54%, which requires therapy discontinuation 2
- Monitor PSA for increases >1.0 ng/mL in any one year 2
Common Pitfalls to Avoid
- Timing errors: Afternoon testing can falsely suggest hypogonadism due to natural circadian variation 3
- Single sample reliance: Testosterone levels vary day-to-day; multiple samples are recommended 4
- Using unreliable assays: Immunoassays often lack accuracy, especially at lower ranges 6
- Ignoring binding protein variations: Total testosterone may be misleading when binding proteins are altered 5
- Failing to consider obesity: This is a major confounder in testosterone level interpretation, especially in diabetic men 1
By following these evidence-based guidelines for testosterone testing, you can accurately identify patients with hypogonadism and provide appropriate treatment recommendations.